Skip to content

Patients › Rehabilitation

Paglabas ni Dupuytren

PDF Evidence

Rehabilitation after Dupuytren's fasciectomy — the extension splint regime and exercise program, with hand-therapist follow-up.

Updated Jun 2026
Illustrasyon ng kamay na may Dupuytren's contracture, kung saan ang mga daliring pang-apat at maliit ay nakabalukta papunta sa palad.
Kontraktura ni Dupuytren: ang matigas na mga kordilya sa palad ay humihila sa mga daliri papunta sa kamay. Kieran Hirpara 4.0

Ang pahinang ito ay isinalin ng makina at hindi pa nasusuri ng isang doktor. Ang bersyong Ingles ang siyang opisyal.

Ang protocol na ito ay gabay sa iyong paggaling pagkatapos ng operasyong pagpapalaya sa Dupuytren’s contracture (fasciectomy) kay Dr. Kieran Hirpara sa Mater Private Hospital Rockhampton. Ang dalawang haligi ng magandang resulta ay ang splint, na pinapanatiling tuwid ang mga daliri habang nagpapagaling ang lahat, at ang programa ng ehersisyo, na pinapanatiling gumagalaw ang mga daliri. Dalhin ang pahinang ito o ang PDF nito sa iyong hand therapist upang manatiling koordinado ang iyong rehabilitasyon.

Kung mayroon kang anumang alalahanin tungkol sa iyong sugat pagkatapos ng operasyon, makipag-ugnayan sa mga kwarto. Madalas na nakakatulong na kumuha ng litrato ng sugat at ipadala ito sa pamamagitan ng email para sa pagsusuri.

Ano ang inaasahan

Ang operasyon para sa sakit ni Dupuytren ay nag-aalis ng mga sira na tali ng tissue na humihila sa iyong mga daliri patungo sa palad, na nagbabalik ng kakayahang tuwidin ang mga ito. Ang kondisyon mismo ay ipinaliwanag sa sakit ni Dupuytren na pahina; walang permanenteng gamot, at ang layunin ng operasyon ay alisin ang sira na tissue at ibalik ang pagtutwid ng daliri.

Karaniwang ire-refer ka sa isang hand therapist 2–3 araw pagkatapos ng operasyon. Gagawa ang therapist ng isang custom na plastic splint na hahawak sa mga operated na daliri sa isang extended (tuwid) na posisyon, at sisimulan ka sa banayad na programa ng ehersisyo sa ibaba. Magtutulungan ang splint at ang mga ehersisyo: ang splint ay nagdepensa sa katuwidan na kinuha ng operasyon, at ang mga ehersisyo ay pinapanatiling yumuyuko ang mga daliri upang hindi sila mahigpit.

Panatilihing malinis at tuyo ang sugat hanggang sa matanggal ang iyong mga sutures. Kapag natanggal na ang mga sutures, maaari mong basain ang balat, ngunit iwasan ang pagbabad o paglubog ng kamay sa tubig sa loob ng isang linggo. Ang pag-aalaga sa sugat na pahina ng klinika ay sumasaklaw sa mga dressing, mga senyales ng impeksyon, at pag-aalaga sa peklat nang detalyado. Mahalaga ang massaging sa peklat pagkatapos ng operasyon ni Dupuytren, at gabayin ka ng iyong therapist dito kapag gumaling na ang sugat.

Pag-aalaga sa iyong peklat

Ang peklat sa palad ay madalas na matigas, nakataas, at masakit sa mga unang linggo pagkatapos ng operasyon para sa Dupuytren bago unti-unting malambot at mawawala ang kulay sa mga sumunod na buwan. Ang masahe ng peklat ay karaniwang bahagi ng paggamot ng kamay sa Australia: sa isang pambansang pagtatanong sa mga akreditadong terapistang kamay, halos lahat ng gumagamit nito pagkatapos ng operasyon sa kamay (karaniwang nagsisimula sa pag-alis ng tahi, kapag lubos nang gumaling ang sugat) upang malambot ang peklat, mapabuti ang paggalaw ng balat sa ibabaw ng mga tisyu sa ilalim, at mapababa ang sensitibidad ng peklat, kadalasang pinagsasama sa silicone gel o sheeting imbes na gamitin nang mag-isa [6]. Ang ebidensya sa pananaliksik tungkol sa masahe ng peklat ay patuloy pa ring umuunlad, ngunit sumusuporta ito sa paggamit nito upang bawasan ang hindi komportableng nararamdaman na dulot ng peklat at mapabuti ang galaw [6]. Ipakikita ng iyong terapeuta ang teknik at maaari itong dagdagan ng produkto ng silicone, kadalasang isinusuot sa gabi kasama ang splint.

Pagbawi, trabaho, at pangmatagalan

Ang pamamaga at katigasan ay normal sa mga unang linggo at humihina habang ginagamit ang kamay; ang kaginhawahan, galaw, at hawak ay karaniwang patuloy na umaayos sa loob ng ilang buwan. Ang pagtaas ng kamay at ang banayad na paggalaw sa mga unang linggo ay tumutulong upang mabawasan ang pamamaga at maiwasan ang pagkatigig ng mga maliit na kasu-kasuan. Ang tuwid na posisyon na nakamit sa operasyon ay karaniwang nananatiling maayos sa panahong ito. Sa isang randomised na pag-aaral tungkol sa rehabilitasyon pagkatapos ng pag-release sa Dupuytren, ang karamihan sa mga operadong daliri ay nanatiling tuwid o nagkaroon ng pagpapabuti sa kanilang extension sa loob ng unang tatlong buwan ng hand therapy [2].

Ang oras ng pagliban sa trabaho ay nakadepende sa kung ano ang iyong ginagawa gamit ang mga kamay. Sa isang pag-aaral na kabilang ang higit sa 2,500 taong naipagamot para sa sakit na Dupuytren, ang median na pagbabalik sa trabaho pagkatapos ng open fasciectomy ay humigit-kumulang dalawang linggo, at humigit-kumulang siyam sa sampung tao ay bumalik sa trabaho sa loob ng isang taon; ang mga trabahong pisikal na mahirap ay nangangailangan ng mas matagal na panahon [4]. Pagtalakayin ni Dr. Hirpara ang tamang oras para sa iyong partikular na trabaho sa review; ang mas mabigat na manual na trabaho ay karaniwang inaantay hanggang sa maging maayos ang paggaling ng sugat at kumportable na ang hawak.

Dahil ang Dupuytren ay isang kondisyong buhay-buhay, maaaring magbalik ang ilang katigasan sa loob ng mga taon, at magkakaiba-iba ang mga ulat na rate ng pagbabalik depende sa kung paano ito tinukoy sa iba't ibang pag-aaral. Ang pangmatagalang larawan ay karaniwang nakapagpapagaan ng isip: sa isang follow-up ng 142 na fasciectomy sa loob ng humigit-kumulang apat na taon gamit ang modernong konsensus na depinisyon, ang tunay na pagbabalik ng contracture ay nangyari sa humigit-kumulang 3–4% ng mga kamay, bagama't humigit-kumulang isang ikatlo ay nanatiling may ilang natitirang kurba, na karaniwang mild at malayo sa contracture na naayos sa operasyon [5]. Ang splint, pangangalaga sa peklat, at programa ng ehersisyo ay lahat ay layunin na protektahan ang iyong resulta; kung ang isang daliri ay magsimulang maging mas matigas sa anumang punto, ipaalam ito sa aming opisina.

Ang iyong splint

  • Unang linggo o higit pa: isuot ang splint sa araw at gabi, alisin lamang ito para sa iyong mga ehersisyo (at paghuhugas, kapag pinapayagan na).
  • Pagkatapos ng unang linggo: karamihan sa mga tao ay lumilipat sa pag-suot ng splint sa gabi lamang, at maaaring magsimulang gumamit ng kamay para sa magaan na gawain sa araw.
  • Patuloy na pag-suot ng splint sa gabi ng mga 3 buwan (at sa ilang kaso hanggang 6 buwan) upang protektahan laban sa pag-draft ng mga daliri pabalik patungo sa palad habang mature ang mga tisyu.
  • Ang iyong hand therapist at Dr. Hirpara ang magbibigay ng partikular na payo tungkol sa iyong schedule ng pag-suot ng splint at gawain. Ang mga oras sa itaas ay ang karaniwang pattern, hindi isang nakatakdang patakaran.

Hindi ka dapat magmaneho habang nasa splint ang iyong kamay. Kapag lumipat ka na sa pag-suot ng splint sa gabi lamang, maaari nang ipagpatuloy ang pagmamaneho sa araw ayon sa kaginhawaan at ligtas na hawak sa manibela.

Para sa iyong physiotherapist / hand therapist:

Pamamahala

  • Referral 2–3 araw pagkatapos ng operasyon para sa paggawa ng thermoplastic extension splint
  • Regimen ng splint: araw at gabi ng humigit-kumulang ang unang linggo (alisin para sa mga ehersisyo), pagkatapos ay gabi lamang na may magaan na functional paggamit sa araw; patuloy na pag-suot ng splint sa gabi ng humigit-kumulang 3 buwan (hanggang 6 buwan kung kinakailangan), ayon sa pagsusuri ng surgeon/therapist
  • Programang ehersisyo sa bahay ayon sa mga card sa ibaba: aktibong extension, blocked DIP flexion, DIP/PIP flexion sa ibabaw ng panulat, composite flexion, wrist tenodesis
  • Pangangalaga sa sugat ayon sa gabay sa pangangalaga sa sugat ng klinika; pamamahala ng peklat kapag nakalagda na
  • Mga paulit-ulit at araw-araw na dalas na itinakda ng nag-oobrang therapist

Mga Paalala

  • Panatilihing malinis at tuyo ang sugat hanggang sa pag-alis ng sutures; huwag magbabad/submerge sa loob ng karagdagang linggo pagkatapos
  • Ang compliance sa pag-suot ng splint ay sentral sa pagpapanatili ng extension na nakamit sa operasyon
  • Walang pagmamaneho habang nasa splint ang kamay

Ito ang mga ehersisyo mula sa iyong handout, nagsimula kasama ang iyong hand therapist at ipinagpatuloy sa bahay.

Ang iyong mga ehersisyo

Pagkatapos ng iyong protocol

Ang protocol na ito ay isinulat kasama si Ruby Doolan, Accredited Hand Therapist mula sa Extend Rehabilitation. Ito ay nagtataglay ng karaniwang payo para sa pagbawi ng pasyente sa aming klinika: tingnan ang pamamahala ng sakit pagkatapos ng operasyon, pag-aalaga sa sugat, at mga batayang impormasyon tungkol sa hand therapy. Para sa operasyon mismo, tingnan ang Dupuytren's fasciectomy.

Ang mga inaasahang resulta sa pagbawi, mga numero para sa pagbabalik sa trabaho, at gabay sa pag-aalaga sa peklat ay nakukuha mula sa mga publikadong pagsubok, pagsusuri, at mga survey sa rehabilitasyon pagkatapos ng operasyon para sa Dupuytren's, kabilang ang mga randomised na pagsubok at isang sistematikong pagsusuri tungkol sa paggamit ng splint at hand therapy pagkatapos ng fasciectomy [1–3]. Ang regimen ng splint at programa ng ehersisyo ay sariling protocol ng aming klinika, na kinilala ni Dr Hirpara at ng iyong hand therapist, at ang iyong schedule sa pagsuot ng splint ay idinidisenyo para sa iyo sa bawat review.

Mga Sanggunian

[1] Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Paggamit ng splint sa gabi pagkatapos ng fasciectomy o dermo-fasciectomy para sa Dupuytren's contracture: isang pragmatiko, multi-sentro, randomised na kontroladong pagsubok. BMC Musculoskeletal Disorders. 2011;12:136. https://pmc.ncbi.nlm.nih.gov/articles/PMC3146906/ [2] Collis J, Collocott S, Hing W, Kelly E. Epekto ng mga orthoses sa pagpapalawak sa gabi pagkatapos ng surgical release ng Dupuytren contracture: isang single-center, randomized, controlled trial. Journal of Hand Surgery (American). 2013;38(7):1285–1294.e2. https://doi.org/10.1016/j.jhsa.2013.04.012 [3] Karam M, Kahlar N, Abul A, Rahman S, Pinder R. Paghahambing ng hand therapy na may o walang splinting pagkatapos ng fasciectomy para sa Dupuytren's contracture: sistematikong pagsusuri at meta-analysis. Journal of Hand and Microsurgery. 2022;14(4):308–314. https://pmc.ncbi.nlm.nih.gov/articles/PMC10042625/ [4] Blake SN, Poelstra R, Andrinopoulou ER, et al. Pagbabalik sa trabaho at kaugnay na gastos pagkatapos ng paggamot para sa Dupuytren's disease. Plastic and Reconstructive Surgery. 2021;148(3):580–590. https://pubmed.ncbi.nlm.nih.gov/34292887/ [5] Radhamony NG, Nair RR, Sreenivasan S, et al. Natitirang deformity kumpara sa pagbalik ng kondisyon pagkatapos ng Dupuytren's palmar fasciectomy — isang long-term follow-up ng 142 kaso. Annals of Medicine and Surgery. 2022;73:103224. https://pmc.ncbi.nlm.nih.gov/articles/PMC8767281/ [6] Scott HC, Robinson LS, Brown T. Pagmamasahe ng peklat bilang interbensyon para sa mga peklat pagkatapos ng operasyon: isang survey ng pagsasanay ng mga hand therapist sa Australia. Hand Therapy. 2024;29(1):21–29. https://pmc.ncbi.nlm.nih.gov/articles/PMC10901164/

Reviewed by Dr Kieran Hirpara · 10 June 2026.

Want the clinical detail? Read the clinician version.

Talk to your treating clinician for advice specific to you.

For an appointment with the CQ Hand + Upper Limb team, ask your GP about a referral or visit www.cqupperlimb.com.

Evidence & references

Dupuytren Contracture — Surgical Release & Post-operative Hand-Therapy Rehabilitation (Open Fasciectomy)

Topic scope: post-operative rehabilitation after open excision of diseased palmar/digital fascia for Dupuytren contracture — limited/regional fasciectomy, extending to dermofasciectomy (fascia plus overlying involved skin, replaced with a graft) for aggressive or recurrent disease. The procedure-selection literature (fasciectomy vs needle aponeurotomy vs collagenase) is summarised only as far as it frames recurrence expectations and rehabilitation; the rehab focus is the post-fasciectomy pathway — early active and passive finger extension and flexion, oedema control, scar management, and night extension splinting.

Defining principle of this rehab: fasciectomy removes diseased tissue and restores extension that the disease had taken away — it does not cure the diathesis, and the corrected finger sits in a tissue bed that wants to contract back. So the rehab is a "regain-and-hold" pathway: early motion to keep the freed joints supple and prevent the new flexor-tendon and skin-glide planes from binding down, oedema and scar control so the soft tissues mature without tethering, and a night extension orthosis to defend the surgical correction during healing. The defining clinical question is not whether a construct needs protection (there is no construct), but how aggressively to splint — and here the evidence has shifted decisively toward selective, not routine, splinting.

A. PROCEDURE OUTCOMES & RECURRENCE (context for the rehab)

Open partial (limited) fasciectomy is the long-standing reference operation for Dupuytren contracture and gives the most durable correction of the three mainstream options:

  • Correction is reliable and recurrence is the dominant long-term limitation. Across modern series the operation restores extension well, but Dupuytren is a lifelong diathesis and some tightening returns over years. Reported recurrence rates vary enormously because studies define recurrence differently (any palpable disease vs a threshold extension loss vs need for re-intervention). Using the modern consensus definition, true recurrence of contracture is low at medium-term follow-up, though a substantial minority retain mild residual curvature well short of the pre-operative deformity [corpus: jhsa.2012.06.032; literature: Radhamony 2022].
  • Fasciectomy vs minimally invasive options. Compared with needle aponeurotomy/fasciotomy and collagenase Clostridium histolyticum, open fasciectomy has a longer recovery and higher minor complication rate but lower recurrence — the recurring trade-off in this disease. Needle and collagenase are quicker with faster return to function but recur sooner [corpus: jhsa.2021.05.022; jhsa.2011.08.004; 1753193418786947]. This trade-off is why fasciectomy is typically chosen for denser, multi-ray or PIP-predominant contractures — the same cases whose rehab is hardest and whose splinting is most likely to be justified.
  • Repeat limited fasciectomy for recurrence is safe and effective, supporting fasciectomy as a durable, repeatable mainstay rather than a one-shot procedure [corpus: bjj-2020-1393.r2].

Why this matters for rehab: recovery counselling and splint expectations must be framed against a disease that cannot be cured, only corrected — the rehab protects a correction, it does not prevent the diathesis.

B. THE SPLINTING CONTROVERSY (the central rehab question)

Historically, every patient was issued a static night extension orthosis after fasciectomy on the assumption it preserved the correction. The best available evidence does not support routine splinting — it supports selective splinting for patients who lose extension.

  • Jerosch-Herold 2011 (pragmatic multi-centre RCT, n = 154). Hand therapy alone vs hand therapy + night splinting after fasciectomy/dermofasciectomy. No between-group difference in self-reported function (DASH), finger range of motion, or satisfaction. Authors concluded routine night splinting for all patients is not recommended, reserving it for cases where extension deficits recur [literature: Jerosch-Herold 2011, BMC Musculoskelet Disord].
  • Collis 2013 (single-centre RCT, n = 56). Night extension orthosis + hand therapy vs hand therapy alone after surgical release. No significant difference in total active extension or any secondary outcome at 3 months. Same conclusion: provide an orthosis selectively, when extension loss occurs, not universally [corpus: jhsa.2013.04.012; literature: Collis 2013].
  • Karam 2022 (systematic review + meta-analysis, 4 RCTs, n = 295). Pooling the splint-vs-no-splint trials found no significant difference in total active flexion/extension, DASH, pain, grip or satisfaction. The collective signal is consistent and now moderately strong: adding a splint to good hand therapy does not improve the average outcome [corpus: 1055/s-0041-1725221; literature: Karam 2022].
  • Earlier/smaller work (e.g., post-fasciectomy splinting pilot studies) pointed the same way — splinting is low-yield as a blanket policy [corpus: 1753193412437631].

Practical reading for this protocol. The practice's pattern — splint day-and-night for ~1 week, then night-only with a low threshold to continue (or reinstate) splinting if a finger starts to drift back into flexion — is a reasonable, evidence-aligned middle path: it defends the correction during the highest-risk early healing window and during sleep, while honouring the trial finding that indefinite routine splinting adds little. The trials measured average outcomes; they do not say splinting is useless for the individual who is losing extension, which is exactly the subgroup the authors carved out. This is a defensible selective-splinting stance, not a contradiction of the protocol.

C. HAND-THERAPY & EXERCISE EVIDENCE

  • Early supervised hand therapy is the backbone of recovery and is where the demonstrable benefit lies (the splint trials all compared against a hand-therapy baseline, not against nothing). Active and passive extension and flexion, oedema control and scar management are standard from the first post-operative therapy visit, typically 2–3 days after surgery.
  • Most operated fingers hold or improve their extension over the first three months of hand therapy — the window in which the protocol concentrates splinting and exercise [corpus: jhsa.2013.04.012, control arm; literature: Collis 2013].
  • Scar management. Scar massage is near-universal in hand-therapy practice after Dupuytren surgery to soften the palmar scar, improve skin glide and settle sensitivity, generally combined with silicone gel/sheeting and begun around suture removal once the wound is healed. The supporting evidence is developing rather than definitive but favours reduced scar-related discomfort and improved movement [literature: Scott 2024, Australian hand-therapist survey].
  • Return to work. In a large cohort, median return after open fasciectomy was ~2 weeks with ~90% back at work within the year; physically demanding jobs took longer [literature: Blake 2021].
  • Pre-operative hand therapy has a thinner evidence base and is not a substitute for the post-operative programme [corpus: 17589983241227162].

Phased rehabilitation timeline (matching the synthesis phases)

Phase Window Splint Movement / use Scar & oedema Notes
I — Protect & mobilise ~Days 2–7 Custom thermoplastic extension orthosis day & night, off for exercises Gentle active extension + active DIP/PIP and composite flexion from the first therapy visit; wrist tenodesis Oedema control (elevation, gentle movement); wound kept clean & dry Therapy referral 2–3 days post-op; splint defends the surgical correction during the highest-risk window
II — Restore motion ~Week 1 → 6–8 Transition to night-only; light functional day use of the hand Progress active + passive extension and flexion; restore full composite fist and full extension Scar massage + silicone once wound healed (around suture removal) Most extension is held or regained through this window; daytime driving resumes once out of the splint and grip is safe
III — Strengthen & return ~Week 6–8 → 3 months Night-only continues ~3 months (up to ~6 months selectively if extension is being lost) Grip and functional strengthening; return to heavier manual work as wound is soundly healed and grip comfortable Ongoing scar maturation over months Splinting beyond this window is selective, driven by extension loss — not routine (see §B)

The phase structure and timings are protocol/consensus, agreed between the surgeon and hand therapist; the trials inform the splinting policy within them, not the exact week boundaries.

D. COMPLICATIONS (rehab-relevant)

  • Flare reaction / early CRPS-spectrum. A proportion of patients develop a post-operative inflammatory "flare" — disproportionate swelling, stiffness, redness and pain — which can progress to complex regional pain syndrome (CRPS type 1). Early recognition, oedema control, gentle continued motion and analgesia matter; CRPS is one of the more feared rehab-derailing complications after hand surgery [corpus: jht.2024.09.002 (Dupuytren CRPS-1 case); hcl.2009.11.001 (CRPS after hand surgery)].
  • Digital nerve / vessel injury. The neurovascular bundles are displaced by Dupuytren cords, especially in recurrent disease and at the PIP; injury is a recognised operative risk. New sensory change post-operatively warrants surgeon review [corpus: hansur.2017.07.002 — complications systematic review; 17531934231206317 — surgical complications/adverse events].
  • Wound healing, haematoma, infection, stiffness. Open fasciectomy has a higher minor-complication rate than the minimally invasive options; meticulous wound care and early motion mitigate stiffness and tethering [corpus: hansur.2017.07.002].
  • Incomplete correction / residual PIP deficit. PIP contractures correct less completely than MCP; residual deficit may persist and is the usual trigger for selective ongoing splinting.

E. KEY CONTROVERSIES / EVIDENCE QUALITY

  1. Routine vs selective splinting — the headline controversy, now reasonably settled toward selective: three RCTs and a meta-analysis show no average benefit from adding a static night orthosis to good hand therapy, with all authors carving out the extension-loss subgroup. The practice's "night-only, low threshold to continue if drifting" approach is consistent with this. Moderate (multiple RCTs + SR/MA).
  2. Recurrence is definition-dependent — headline recurrence figures are not comparable across studies; the consensus definition gives lower, more credible rates. Counsel against the cure expectation. Moderate.
  3. Procedure choice frames rehab — fasciectomy trades a longer recovery and more minor complications for lower recurrence than needle/collagenase. The fasciectomy cohort is, by selection, the harder-rehab cohort. Moderate.
  4. The phase timings are consensus — drawn from surgeon/therapist protocols, not a rehab RCT. The splinting policy within them is trial-informed; the week boundaries are typical, not trial-derived. Weak/consensus.

F. EVIDENCE STRENGTH FLAGS (summary)

  • MODERATE (multiple RCTs + SR/MA): routine night splinting adds no average benefit over hand therapy alone after fasciectomy — splint selectively for extension loss (Jerosch-Herold 2011; Collis 2013; Karam 2022 meta-analysis of 4 RCTs / 295 patients).
  • MODERATE (cohorts / comparative): fasciectomy gives durable correction with lower recurrence but longer recovery and more minor complications than needle aponeurotomy/collagenase; repeat fasciectomy is safe and effective; CRPS and digital-nerve injury are recognised rehab-relevant complications.
  • WEAK / CONSENSUS: the post-operative phase structure and timings themselves (surgeon + hand-therapist protocol; no defining rehab RCT). Scar-massage benefit is supportive but the evidence base is still developing.

CITATIONS

RAG corpus (180,000+ Orthopaedic articles)

  • Correction of contracture and recurrence rates of Dupuytren contracture following fasciectomy. J Hand Surg Am. 2012. DOI: 10.1016/j.jhsa.2012.06.032
  • Repeat limited fasciectomy is a safe and effective treatment for recurrence of Dupuytren's contracture. Bone Joint J. 2021. DOI: 10.1302/0301-620X.103B5.BJJ-2020-1393.R2
  • Limited fasciectomy versus collagenase Clostridium histolyticum for Dupuytren contracture. J Hand Surg Am. 2021. DOI: 10.1016/j.jhsa.2021.05.022
  • The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture. J Hand Surg Eur. 2011. DOI: 10.1177/1753193410397971
  • Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg Am. 2011. DOI: 10.1016/j.jhsa.2011.08.004
  • Three-year recurrence of Dupuytren's contracture after needle fasciotomy and collagenase injection. J Hand Surg Eur. 2018. DOI: 10.1177/1753193418786947
  • The effect of night extension orthoses following surgical release of Dupuytren contracture: a single-centre RCT. J Hand Surg Am. 2013. DOI: 10.1016/j.jhsa.2013.04.012
  • Comparison of hand therapy with or without splinting postfasciectomy for Dupuytren's contracture: systematic review and meta-analysis. J Hand Microsurg. 2022. DOI: 10.1055/s-0041-1725221
  • Does use of a night extension orthosis improve outcomes in patients with Dupuytren contracture? J Hand Surg Glob Online. 2021. DOI: 10.1016/j.jhsg.2021.05.001
  • A pilot study assessing the effectiveness of postoperative splinting after limited fasciectomy. J Hand Surg Eur. 2012. DOI: 10.1177/1753193412437631
  • Pre-operative hand therapy management of Dupuytren's disease: a systematic review. Hand Ther. 2024. DOI: 10.1177/17589983241227162
  • Current concepts in the management of Dupuytren disease of the hand. J Am Acad Orthop Surg. 2020. DOI: 10.5435/JAAOS-D-20-00190
  • Complications after treating Dupuytren's disease: a systematic literature review. Hand Surg Rehabil. 2017. DOI: 10.1016/j.hansur.2017.07.002
  • Surgical complications: errors and adverse events (hand surgery). J Hand Surg Eur. 2023. DOI: 10.1177/17531934231206317
  • The case of a woman with bilateral Dupuytren's contractures who developed CRPS-1. J Hand Ther. 2024. DOI: 10.1016/j.jht.2024.09.002
  • Complex regional pain syndrome after hand surgery. Hand Clin. 2009. DOI: 10.1016/j.hcl.2009.11.001

Splinting & hand-therapy literature (URLs)

  • Jerosch-Herold C, Shepstone L, Chojnowski AJ, et al. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskelet Disord. 2011;12:136. https://pmc.ncbi.nlm.nih.gov/articles/PMC3146906/
  • Collis J, Collocott S, Hing W, Kelly E. The effect of night extension orthoses following surgical release of Dupuytren contracture: a single-centre, randomised, controlled trial. J Hand Surg Am. 2013. https://pubmed.ncbi.nlm.nih.gov/23790420/
  • Karam M, Kahlar N, Abul A, et al. Comparison of hand therapy with or without splinting postfasciectomy for Dupuytren's contracture: systematic review and meta-analysis. J Hand Microsurg. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC10042625/
  • Blake SN, Poelstra R, Andrinopoulou ER, et al. Return to work and associated costs after treatment for Dupuytren's disease. Plast Reconstr Surg. 2021. https://pubmed.ncbi.nlm.nih.gov/34292887/
  • Radhamony NG, Nair RR, Sreenivasan S, et al. Residual deformity versus recurrence following Dupuytren's palmar fasciectomy — long-term follow-up of 142 cases. Ann Med Surg. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC8767281/
  • Scott HC, Robinson LS, Brown T. Scar massage as an intervention for post-surgical scars: a practice survey of Australian hand therapists. Hand Ther. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10901164/

Society guidance & published rehab protocols

  • The British Society for Surgery of the Hand (BSSH) — Dupuytren's disease patient and professional guidance. https://www.bssh.ac.uk/patients/conditions/25/dupuytrens_disease
  • BSSH — Assessing the outcome of surgery for Dupuytren's disease of the hand. https://www.bssh.ac.uk/assessing_the_outcome_of_surgery_for_dupuytrens_disease_of_the_hand.aspx

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.